Myelosuppressive chemotherapy to mobilize normal stem cells in chronic myeloid leukemia

Bone Marrow Transplantation

Volumn 17, Issue 1, 1996, Pages 25-29

  Mehta, J ^a   Mijovic A ^b   Powles, R ^a   Pagliuca, A ^b   Singhal, S ^a   Czepulkowski, B ^b   Swansbury, G J ^a   Treleaven, J ^a   Mufti, G J ^b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Autograft; Chronic myeloid leukemia; G CSF; Peripheral blood stem cell transplantation; Philadelphia chromosome

Indexed keywords

ALPHA INTERFERON; BUSULFAN; CD34 ANTIGEN; CYTARABINE; ETOPOSIDE; IDARUBICIN; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOGRAFT; BONE MARROW SUPPRESSION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; COLONY FORMING UNIT GM; CYTAPHERESIS; CYTOGENETICS; FEMALE; GRAFT FAILURE; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MALE; METAPHASE; MONONUCLEAR CELL; NEUTROPHIL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; MIDDLE AGED; TRANSPLANTATION, AUTOLOGOUS;

EID: 0030069723     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kantarjian HM, Deisseroth A, Kurzrock R et al. Chronic myelogenous leukemia: a concise update. Blood 1993; 82: 691-703.
2. Clift RA, Appelbaum FR, Thomas ED. Treatment of chronic myeloid leukemia by marrow transplantation. Blood 1993; 82: 1954-1956.
3. McGlave P, Bartsch G, Anasetti C et al. Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program. Blood 1993; 81: 543-550.
4. The Italian Cooperative Study Group on Chronic Myeloid Leukemia. Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. New Engl J Med 1994; 330: 820-825.
5. McGlave PB, De Fabritiis P, Deisseroth A et al. Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups. Lancet 1994; 343: 1486-1488.
6. Mehta J. Graft-versus-leukemia reactions in clinical bone marrow transplantation. Leuk Lymphoma 1993; 10: 427-432.
7. Fefer A, Radich J, Pavletic Z et al. Syngeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia in chronic phase: update of the original 14 Seattle patients including PCR results. Blood 1994; 84 (suppl. 1): 252a.
8. Lo Coco F, Mandelli F, Diverio D et al. Therapy-induced Ph1 suppression in chronic myeloid leukemia: molecular and cytogenetic studies in patients treated with alpha-2b IFN. high-dose chemotherapy and autologous stem cell infusion. Bone Marrow Transplant 1990; 6: 253-258.
9. Eaves CJ, Barnett MJ, Eaves AC. In vitro culture of bone marrow cells for autograftins in CML. Leukemia 1993; 7 (suppl. 2): S126-S129.
10. McGlave PB, Arthur D, Miller WJ et al. Autologous transplantation for CML using marrow treated ex vivo with recombinant human interferon gamma. Bone Marrow Transplant 1990; 6: 115-120.
11. Carlo Stella C, Mangoni L, Piovani G et al. In vitro marrow purging in chronic myelogenous leukemia: effect of mafosfamide and recombinant granulocyte-macrophage colony-stimulating factor. Bone Marrow Transplant 1991; 8: 265-273.
12. Carella AM, Gaozza E, Raffo MR et al. Therapy of acute phase chronic myelogenous leukemia with intensive chemotherapy, blood cell autotransplant and cyclosporine A. Leukemia 1991; 5: 517-521.
13. Carella AM, Pollicardo N, Raffo MR et al. Intensive conventional chemotherapy can lead to a precocious overshoot of cytogenetically normal blood stem cells (BSC) in chronic myeloid leukemia and acute lymphoblastic leukemia. Leukemia 1992; 6 (suppl. 4): 120-123.
14. Carella AM, Podesta M, Frassoni F et al. Collection of 'normal' blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia. Bone Marrow Transplant 1993; 12: 267-271.
15. Carella AM, Pollicardo N, Pungolino E et al. Mobilization of cytogenetically 'normal' blood progenitors cells by intensive conventional chemotherapy for chronic myeloid and acute lymphoblastic leukemia. Leuk Lymphoma 1993; 9: 477-483.
16. Powles R, Mufti GJ, Mehta J et al. Harvesting peripheral blood stem cells after myelosuppressive chemotherapy in chronic myeloid leukaemia. Br J Haematol 1995; 89 (suppl. 1): 38.
17. Kantarjian HM, Talpaz M, Hester J et al. Collection of peripheral-blood diploid cells from chronic myelogenous leukemia patients early in the recovery phase from myelosuppression induced by intensive-dose chemotherapy. J Clin Oncol 1995; 13: 553-559.
18. Deisseroth AB, Zu Z, Claxton D et al. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 1994; 83: 3068-3076.
19. Talpaz M, Kantarjian H, Liang J et al. Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional-dose chemotherapy before collection of autologous cells. Blood 1995; 85: 3257-3263.
20. Mehta J. Interferon alfa-2a for chronic myeloid leukemia. New Engi J Med 1994; 331: 401-402.
21. O'Brien SG, Rule S, Spencer A et al. Autografting in chronic phase CML using PBPCs mobilized by intermediate-dose chemotherapy. Br J Haematol 1995; 89 (suppl. 1): 39.
22. Kuss BJ, Sage RE, Shepherd KM et al. High-dose hydroxyurea in collection of Philadelphia chromosome-negative stem cells in chronic myeloid leukaemia. Leuk Lymphoma 1993; 10: 73-78.
23. Johnson RJ, Owen RG. Morgan GJ et al. Oral hydroxyurea (HU) and rhG-CSF (Neupogen) mobilisation of Philadelphia negative stem cells in patients with CGL. Br J Haematol 1995; 89 (suppl. 1): 6.
24. Clift RA, Buckner CD, Thomas ED et al. Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood 1994; 84: 2036-2043.